Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ropivacaine For Post-POEM Pain Control

NCT03702647 is registered in ClinicalTrials.gov with Lawrence Charles Hookey as lead sponsor.

NCT NCT03702647
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03702647 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ropivacaine For Post-POEM Pain Control
Lead sponsor
Lawrence Charles Hookey
Phase
Not applicable
Overall status
Completed
Start date
June 1, 2019
Completion date
January 18, 2021
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

achalasia, esophageal achalasia